MIST
NASDAQ · Pharmaceuticals
Milestone Pharmaceuticals In
$1.22
+0.04 (+3.39%)
Open$1.18
Previous Close$1.18
Day High$1.22
Day Low$1.16
52W High$3.06
52W Low$1.00
Volume—
Avg Volume1.32M
Market Cap151.27M
P/E Ratio—
EPS$-0.68
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+3,623.8% upside
Current
$1.22
$1.22
Target
$45.43
$45.43
$30.70
$45.43 avg
$53.70
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.36M | 3.49M | 19.07M |
| Net Income | -96,360,951 | -128,253,262 | 5.86M |
| Profit Margin | -4,078.8% | -3,874.8% | 30.7% |
| EBITDA | -94,784,206 | -133,163,258 | 12.52M |
| Free Cash Flow | — | — | 4.46M |
| Rev Growth | -32.4% | -32.4% | +19.4% |
| Debt/Equity | 1.37 | 1.37 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |